Today: 30 April 2026
Nebius (NBIS) stock slips after insider sale notices hit SEC filings in thin year-end trade
30 December 2025
2 mins read

Nebius (NBIS) stock slips after insider sale notices hit SEC filings in thin year-end trade

NEW YORK, December 29, 2025, 19:45 ET — After-hours

  • Nebius Group shares fell 1.8% to $86.04 after filings flagged planned insider sales tied to “sell-to-cover” transactions. SEC+2SEC+2
  • Founder Arkady Volozh and two other insiders disclosed plans to sell a combined 45,600 shares, with trades listed for Dec. 31 and Jan. 2.
  • The Nasdaq fell 0.5% as investors trimmed risk positions into the final sessions of 2025.

Nebius Group N.V. shares slid on Monday after SEC filings showed founder Arkady Volozh and two other insiders planned share sales around year-end. The stock was down 1.8% at $86.04 in late trade.

The notices matter now because NBIS has been a high-beta trade — a stock that tends to swing more than the market — and additional supply can weigh on prices when liquidity is thin in the final days of the year.

The filings landed as U.S. stocks dipped broadly, with the Nasdaq ending down 0.5%. “We’re seeing a reversal of what we saw over the last couple of days,” said Rob Haworth at U.S. Bank Wealth Management. Investing.com Australia

Nebius traded between $84.25 and $88.55 on Monday, with about 8.1 million shares changing hands, according to trade data.

Three Form 144 filings dated Dec. 29 listed proposed sales of 41,000 shares by Volozh and 2,300 shares each by Nave Ophir and Elena Bunina, for a combined 45,600 shares, or about $4.0 million based on the indicative pricing in the filings.

A Form 144 is a notice that an affiliate of a company plans to sell shares under Rule 144; it is not confirmation the sale has occurred. The filings described the sales as “sell-to-cover” transactions — shares sold to cover taxes tied to equity awards and board compensation — and listed planned trade windows on Dec. 31 and Jan. 2. SEC+2SEC+2

Nebius, a Netherlands-based AI infrastructure provider, has drawn investor attention this year after it signed multi-billion dollar supply agreements to provide GPU capacity — high-end chips used to train and run AI models — to Microsoft and Meta.

In a Nov. 12 regulatory filing describing the Meta agreement, the company said the GPU services were slated to be deployed in two tranches during December 2025 and February 2026, alongside storage and connectivity.

Investors have also focused on how Nebius funds its buildout. The company raised $4.2 billion through a public share offering and sale of convertible notes after the Microsoft deal, Reuters reported earlier this month.

On the last earnings update, Nebius reported a sharp rise in capital spending and a wider quarterly loss, even as it disclosed the Meta deal, underscoring the cash demands of scaling data center capacity.

Nebius competes for enterprise workloads with U.S. hyperscalers such as Amazon and Google, while pitching specialized AI infrastructure to customers that want access to advanced GPUs and related software, Reuters has reported.

Traders will be watching whether the planned sell-to-cover transactions show up in tape data during the thin holiday week, and whether the stock holds above Monday’s $84 area while liquidity remains patchy into year-end.

Nebius has not posted its next earnings date under “Upcoming Events” on its investor events calendar, leaving the next scheduled update unclear as the market heads into the final sessions of 2025. nebius.com

Stock Market Today

  • Park Medi World Stock Dips After Strong 56% YTD Gain Amid Expansion Plans
    April 30, 2026, 3:57 AM EDT. Park Medi World shares fell 0.52% to ₹234 on the NSE after early gains on April 30, despite a robust 56% year-to-date return. The healthcare company's stock initially rallied following a 'buy' rating from Choice Institutional Equities, which set a ₹320 target price, citing expected compound annual growth rates (CAGR) of 26.3% revenue, 27.1% EBITDA, and 34.6% PAT through 2026-2029. The broker highlighted growth drivers including capacity expansion, improved case mix, and payor mix optimization. Park recently opened a multispecialty hospital in Panchkula, expanding its Northern India presence alongside ongoing developments in Mohali. The group operates 16 hospitals with nearly 4,000 beds, targeting 5,460 beds by 2028. The stock's resilience contrasts broader market weakness, gaining 2.39% weekly and 23.28% monthly, reflecting investor confidence in its expansion and operational strategy.

Latest article

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

Australia Stock Market Today: ASX 200 Falls Again as Oil Shock, Woolworths Warning Hit Shares

30 April 2026
Australian shares fell for an eighth straight session Thursday, with the S&P/ASX 200 closing down 0.24% at 8,665.8 as miners and consumer staples dropped. The decline followed data showing annual inflation rose to 4.6% in March, above the Reserve Bank’s target. Woolworths shares slid up to 9.8% after warning on earnings. Oil prices hit a four-year high, lifting energy stocks 1.4%.
Caterpillar stock today: CAT slips in after-hours as year-end trading thins out
Previous Story

Caterpillar stock today: CAT slips in after-hours as year-end trading thins out

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes
Next Story

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Go toTop